Labcorp EVP Amy Summy sells $283k in common stock By Investing.com

Amy B. Summy, Executive Vice President and Chief Marketing Officer at LABCORP HOLDINGS INC. (), disposed of shares of the company’s common stock on August 4, 2026. The transaction involved the sale of 924 shares for a total value of $283,427.

The shares were sold at a price of $306.74 per share. The stock currently trades at $313.96, near its 52-week high of $316.11, with shares up 25.8% year-to-date. Following this transaction, Ms. Summy directly holds 6,955.50 shares of Labcorp common stock.According to InvestingPro analysis, Labcorp appears undervalued at current levels, with a Fair Value of $320.09. The company maintains a perfect Piotroski Score of 9, while management has been aggressively buying back shares. These insights are among 11 total InvestingPro Tips available for LH, along with a comprehensive Pro Research Report covering the healthcare services provider.

In other recent news, Labcorp Holdings reported second-quarter results that exceeded Wall Street expectations. The company’s adjusted earnings per share rose to $4.99, surpassing analysts’ forecast of $4.79. Labcorp’s revenue also saw an increase of 5.8%, reaching $3.73 billion, which was slightly above the anticipated figures. These results were attributed to stronger-than-expected earnings, steady revenue growth, and expanding margins. Furthermore, Labcorp has lifted its full-year outlook, indicating confidence in its ongoing performance. The positive financial results come as a notable development for investors, as the company continues to deliver on its strategic goals. Analysts had projected these earnings, and Labcorp’s performance has aligned well with these expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.